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Abstract. 
 
Myoblast fusion is essential to muscle tissue 
development yet remains poorly understood. N-cad-
herin, like other cell surface adhesion molecules, has 
been implicated by others in muscle formation based 
on its pattern of expression and on inhibition of myo-
blast aggregation and fusion by antibodies or peptide 
mimics. Mice rendered homozygous null for N-cad-
herin revealed the general importance of the molecule 
in early development, but did not test a role in skeletal 
myogenesis, since the embryos died before muscle for-
mation. To test genetically the proposed role of N-cad-
herin in myoblast fusion, we successfully obtained 
N-cadherin null primary myoblasts in culture. Fusion of 
myoblasts expressing or lacking N-cadherin was found 
to be equivalent, both in vitro by intracistronic comple-
mentation of lacZ and in vivo by injection into the mus-
cles of adult mice. An essential role for N-cadherin in 
mediating the effects of basic fibroblast growth factor 
was also excluded. These methods for obtaining geneti-
cally homozygous null somatic cells from adult tissues 
should have broad applications. Here, they demon-
strate clearly that the putative fusion molecule, N-cad-
herin, is not essential for myoblast fusion.
 
E
 
vidence
 
 that N-cadherin, a calcium-dependent, cell
surface adhesion molecule, plays a role in myoblast
fusion is drawn from its spatial and temporal pat-
tern of expression (8, 10, 14, 19, 22) and from blocking
studies either with antibodies specific to extracellular do-
mains of N-cadherin or with peptides designed to mimic
the homophilic binding site conserved among various cad-
herins (18, 22). A major caveat of studies using such block-
ing agents (18, 22, 23, 32, 40) is that the results may derive
from indirect effects: nonspecific binding to other mole-
cules or antagonistic activity such as steric hindrance that
prevents physical approximation. Alternatively, such block-
ing agents can have agonistic or other secondary effects of
ligand binding such as initiation of signal transduction (6,
24, 34). Genetic studies in which the molecule of interest is
entirely eliminated have at times overcome these prob-
lems (4, 5, 35). However, mice lacking N-cadherin exhibit
severe defects in neurulation, somitogenesis, and develop-
ment of the myocardium, dying as 9-d embryos before
muscle tissue formation (30). In some cases, such lethality
has been overcome by producing chimeric mice, created
by implanting embryonic stem (ES)
 
1
 
 cells homozygous for
a mutation of interest into wild-type blastocysts (9, 39).
Tissues analyzed from a significant number of chimeric
mice can be informative about the function of the mutated
gene, especially if the proportion of null cells is skewed: a
high proportion suggests the molecule is nonessential,
whereas a low proportion suggests it is required. Unfortu-
nately in the case of N-cadherin, selection of null ES cells
necessary for the generation of chimeras has been unsuc-
cessful to date. Thus, a genetic analysis of N-cadherin
function in skeletal myogenesis has not previously been
possible.
To overcome these problems and test genetically the
role of N-cadherin in skeletal muscle fusion in vitro and in
vivo, we undertook the novel approach of selecting myo-
blasts that were genetically null for N-cadherin. In this re-
port, we show that myoblasts lacking or expressing N-cad-
herin fuse equivalently both in culture and in the muscles
of adult mice, thus ruling out an essential role for N-cad-
herin in the process of myoblast fusion.
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Abbreviations used in this paper
 
: bFGF, basic fibroblast growth factor;
ES, embryonic stem.
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Materials and Methods
 
G418 Selection of Homozygous Primary Myoblasts 
Lacking N-Cadherin
 
A heterozygous N-cadherin–deficient male mouse was created by homol-
ogous recombination (30) and was mated to a wild-type C57 BL/6 female.
Primary myoblasts were isolated and purified, as described (31) from a lit-
ter of eight 1-wk-old pups. Myoblasts were maintained in growth medium
(GM) as in (31) except that 40% Ham’s F10 and 40% DME were used
and G418 (0.2 mg/ml) was included in the medium until myoblasts had
grown to 
 
z
 
2 
 
3
 
 10
 
7
 
 cells. At this point they were plated at a subconfluent
density of 
 
z
 
5 
 
3
 
 10
 
5
 
 cells/150-mm culture dish and subjected to stringent
selection in G418 (5 mg/ml) for 3 wk in GM buffered to pH 7.2 with 10
mM Hepes. Of 96 clones isolated and transferred to a microwell plate, 6
grew significantly after 3 wk of further selection. Genomic DNA was iso-
lated from these clones, ethanol precipitated, digested with EcoRV, and
screened for wild-type or disrupted N-cadherin alleles by Southern hy-
bridization as described (30). Null clones were further subcloned to assure
homozygosity. For Western blot analysis, myoblasts were maintained in
GM or grown for 4 d in differentiation medium (DM) as in (31), except
that 5% horse serum was used. Cells were lysed and 20 
 
m
 
g protein from
myoblasts or myotubes of each clone was electrophoresed and transferred
to PVDF membrane (Millipore Corp., Bedford, MA). Blots containing
replicate samples were probed with (
 
a
 
) MNCD-2, a rat monoclonal anti-
body to a fusion protein containing amino acids 308–597 specific to the ex-
tracellular domain of mouse N-cadherin (20); (
 
b
 
) with mouse monoclonal
antibody (C1821; Sigma Chemical Co., St. Louis, MO) to a synthetic pep-
tide corresponding to the COOH-terminal 24 amino acids of chicken
N-cadherin; or (
 
c
 
) with anti-pan cadherin, a rabbit polyclonal antibody
made to a GST fusion to the entire COOH-terminal domain of E-cad-
herin, a domain that is highly conserved among most members of the cad-
herin family of molecules including M-, R-, and N-cadherins (generous gift
of W.J. Nelson, Stanford University, Stanford, CA). Antibody binding
was detected with HRP-conjugated sheep anti–rat IgG (Sigma Chemical
Co.), sheep anti–mouse IgG, or donkey anti–rabbit IgG and enhanced
chemiluminescence reagents (Amersham Corp., Arlington Heights, IL).
 
Chemiluminescent Assay
 
Separate populations of N-cadherin–lacking (
 
2
 
/
 
2
 
) or N-cadherin–expressing
(
 
1
 
/
 
2
 
) myoblasts were transduced with retroviral constructs encoding
nonfunctional complementing mutant peptides (
 
Dv
 
 and 
 
Dm
 
) of the 
 
b
 
-galac-
tosidase enzyme as described (25). Cells expressing one peptide were
mixed at equal densities with cells of the same type expressing the comple-
menting peptide, allowed to attach overnight in 96-well microplates, after
which GM was changed to DM with or without recombinant human basic
fibroblast growth factor (bFGF; Promega, Madison, WI) and replaced
daily. At the indicated time points, cells were lysed, processed as de-
scribed (25) for chemiluminescent assay using the Galacton-Plus chemilu-
minescent detection kit (Tropix, Bedford, MA), and enzyme activity was
measured with a luminometer (MicroBeta 1450; Wallac Inc., Gaithers-
burg, MD). Data are expressed as the means of eight replicate wells 
 
6
 
SD.
In some experiments, heterozygous clones were compared to homozygous
null ones since they most resembled null clones in strain background and
passage number, factors known to affect myoblast fusion.
 
Fusion Index
 
Cells assayed for fusion index were treated identically to those in chemilu-
minescent assays except that they were fixed, stained with methylene blue,
and random fields photographed. Each value derived from four indepen-
dent fields scored at 250
 
3
 
. Standard error of the proportion was com-
puted as  , where 
 
 
 
is the estimated proportion of the whole
population of nuclei found in myotubes at a given time point.
 
Tricolor Fluorescent Histochemistry
 
Populations of myoblasts were labeled with complementing segments of
the 
 
lacZ
 
 gene as described (25), mixed together in equal portions, and
plated on sterile collagen-coated glass coverslips. Fusing cells were fixed
for 4 min in 4% paraformaldehyde and then blocked in PBS with 10%
horse serum. 
 
b
 
-galactosidase activity was detected with 25 
 
m
 
g/ml Fast red
violet-LB salt (Sigma Chemical Co.) plus 100 
 
m
 
g/ml 5-bromo-6-chloro-3-
indolyl-
 
b
 
-
 
d
 
-galactopyranoside (Fluka Chemika-Bio Chemika, Buchs, Swit-
Ö (12 )/n p ^ p ^ p ^
 
zerland) in PBS after labeling nuclei with DAPI (Sigma Chemical Co.)
and myotube membranes with rat anti-NCAM antibody (Chemicon Inter-
national, Inc., Temecula, CA; 10, 19, 22), biotinylated goat anti–rat second-
ary antibody (Vector Laboratories, Burlingame, CA), and Cy5-labeled
streptavidin (Amersham Corp.). Triple-labeled deconvolved images were
collected using a deconvolution microscope (Delta Vision; Applied Preci-
sion Inc., Mercer Island, WA).
 
Transplantation of 
 
b
 
-Galactosidase–Labeled Cells into 
Muscles of Nude Mice
 
Primary myoblasts were transduced with a retroviral construct, MFG KB5
containing the full length 
 
lacZ
 
 gene (25), exposed to the substrate fluores-
cein di-
 
b
 
-
 
d
 
-galactopyranoside (Molecular Probes, Eugene, OR) and cells
expressing 
 
b
 
-galactosidase isolated with the fluorescence-activated cell
sorter as described (28). Injections of 
 
b
 
-galactosidase–positive cells into
nude mice (two injections/leg; 5 
 
3
 
 10
 
5
 
 cells/injection) were as described
(31). After 2 or 12 d, mice were killed and muscle dissected, cryofrozen,
sectioned, stained as described (31), and photographed using differential
interference optics.
 
Results
 
G418 Selection of Homozygous Primary Myoblasts 
Lacking N-Cadherin
 
A phenotypically normal adult mouse heterozygous for a
targeted disruption of the N-cadherin gene (30) was mated
with a wild-type mouse. Primary myoblasts from a mixed
litter of heterozygous N-cadherin–deficient and wild-type
pups were pooled, enriched to eliminate nonmyogenic cell
types, and grown to high numbers according to previously
published methods (31). The cells were then exposed to
low G418 selection media, a treatment that yielded a rela-
tively pure population of heterozygous cells as indicated
by a shift in the ratio of wild-type to mutant alleles from
 
z
 
2:1 to 1:1 by Southern analysis (Fig. 1 
 
A
 
). To select for
homozygous mutant myoblasts, this heterozygous myo-
blast population was then subjected to more stringent se-
lection in high G418. Sparse plating of cells was critical in
this procedure as G418 is only selective against actively
growing cells. A dose-response curve revealed a require-
ment for a significantly higher concentration of G418 to
kill most unwanted heterozygous myoblasts than that pre-
viously reported for ES cells (26), yet the efficiency of re-
covery of clones was in the same range. Most clones grew
very slowly in this concentration of G418. Of the six that
formed large-size colonies and were assayed for conver-
sion to homozygosity, two (H7 and G12) were found to
harbor only mutant N-cadherin alleles by Southern analy-
sis (Fig. 1 
 
B
 
). Probing of Western immunoblots with either
a monoclonal antibody that specifically recognizes the ex-
tracellular domain of N-cadherin or with a monoclonal an-
tibody to the COOH-terminal 24 amino acids of N-cad-
herin demonstrated detectable protein of the proper
molecular weight in wild-type cultures but not in null
clones. By contrast, a Western blot of these same samples
probed with a polyclonal antibody to the full COOH-ter-
minal domain that is highly conserved among most mem-
bers of the cadherin family including M- and R-cadherin
revealed other cadherin protein(s) on N-cadherin null myo-
blasts and myotubes (Fig. 1 
 
C
 
). Although cells of the H7
null clone exhibited somewhat rounded morphology and
slow growth, cells of one heterozygous clone did as well.
Thus, these characteristics can be attributed to clonal vari- 
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ation rather than lack of N-cadherin surface protein. By
microscopic analysis, all heterozygous and homozygous
null clones fused extensively.
 
Quantitation of Fusion Potential of
N-Cadherin–Expressing or Null Myoblasts In Vitro
 
We assessed the fusion potential of N-cadherin–expressing
and -nonexpressing myoblasts in tissue culture. Fusion was
measured using chemiluminescence by adapting a recently
developed method based on intracistronic complementa-
tion of the 
 
lacZ
 
 gene in mammalian cells (25). Briefly, as
applied here, the assay involved infecting replicate pri-
mary muscle cell cultures with retroviruses that encoded
one of two nonfunctional mutant 
 
b
 
-galactosidase peptides.
Functional enzyme was only produced upon myoblast fu-
sion, at which point the two peptides were able to come in
contact, assemble, and complement one another. Shown
for the first time (Fig. 2 
 
A
 
) is evidence that this quantita-
tive biochemical assay yields results in good agreement
with those obtained by the slower, more labor-intensive
microscopic scoring of fusion index. In addition, the activ-
ity of complemented 
 
b
 
-galactosidase was assayed in situ
with a novel fluorescent substrate, and when visualized to-
gether with other fluorescent markers of nuclei and myo-
tube membranes, clearly demonstrated fusion at the single
cell level (Fig. 2 
 
B
 
). Conclusive evidence for differentia-
tion was provided by the observation that the N-cadherin
null myofibers actively contracted in culture. Thus, data
from both biochemical and microscopic assays of fusion
were in good agreement and showed that the kinetics and
extent of fusion were similar for myoblasts expressing or
totally lacking N-cadherin.
 
Fusion Potential of N-Cadherin–Expressing and Null 
Myoblasts In Vivo
 
To determine whether N-cadherin is essential for fusion to
occur in vivo, we injected mutant myoblasts into the mus-
cles of adult mice and monitored their fusion with pre-
existing host muscle fibers (29, 31). These experiments
were of particular importance, since the fusion behavior of
myoblasts in vitro can differ markedly from that in vivo;
see for example, studies of myogenin null myoblasts (13,
27). Myoblasts were marked by infection with a replica-
tion-defective retrovirus encoding the full-length 
 
b
 
-galac-
tosidase enzyme and injected into the tibialis anterior
muscles of nude mice (31). Fusion of homozygous null (
 
2
 
/
 
2
 
), heterozygous (
 
1
 
/
 
2
 
), and wild-type (
 
1
 
/
 
1
 
) myoblasts
with muscle fibers was indistinguishable when visualized
histologically. In all cases, irrespective of N-cadherin ex-
pression, 2 d after injection unfused myoblasts were found
in clusters (Fig. 3, 
 
top left
 
), whereas 12 d after injection,
myoblasts were localized in fields of hundreds of large di-
ameter 
 
b
 
-galactosidase–containing fibers (Fig. 3, remain-
ing images). These results demonstrate that N-cadherin is
not required for myoblasts to gain access to host fibers and
fuse into pre-existing syncytia of adult muscles.
 
Effect of Basic Fibroblast Growth Factor on Fusion of 
N-Cadherin Null Myoblasts
 
Several cell adhesion molecules, including N-cadherin,
share a homologous domain with the FGF receptor (38),
and cell adhesion molecules generally have been impli-
cated in signal transduction pathways, some of which in-
volve myogenic migration and differentiation (1, 3, 11, 12,
15, 21). Indeed, N-cadherin has been shown to activate a
second messenger pathway involving a tyrosine kinase
that is similar, if not identical, to that activated by bFGF in
neurons (37). To test genetically whether N-cadherin is in-
volved in mediating effects of bFGF on myoblast differen-
tiation we employed the rapid biochemical assay of fusion
described above based on 
 
b
 
-galactosidase complementa-
tion. The dose-response curve exhibited by N-cadherin
null and N-cadherin–expressing myoblasts was similar and
led to half maximal inhibition of fusion at 0.45 ng/ml bFGF
in good agreement with previous microscopic assays of
wild-type primary myoblasts (31) (Fig. 4). These results
demonstrate that N-cadherin expression in vitro is not es-
sential for transduction of the bFGF signal to myoblasts.
Figure 1. G418 selection of homozygous primary myoblasts lack-
ing N-cadherin. (A) Southern blot analysis of a population of pri-
mary myoblasts isolated and purified from leg muscles of progeny
of a wild-type X heterozygous cross reveals a mixture of homozy-
gous wild-type and heterozygous cells (lane 1: 1/1, 1/2) that
were rendered purely heterozygous (lane 2: 1/2) after growth in
low-dose G418. (B) Southern blot analysis of six clones of pri-
mary myoblasts (B9, C10, D3, G11, G12, H7) after selection in
high-dose G418 demonstrates that clones G12 and H7 myoblasts
have been rendered genetically homozygous null for N-cadherin.
(C) Western blot analysis of wild-type, G12, and H7 cells with an-
tibodies that specifically recognize the extracellular domain (NE)
or that recognize the COOH-terminal 24 amino acid sequence
(NC) of N-cadherin confirms that the genetically null G12 and H7
clones lack N-cadherin protein both as undifferentiated myo-
blasts (mb) and as syncytial myotubes (mt). Probing of same sam-
ples with a polyclonal antibody made to the entire highly con-
served COOH-terminal domain common to many cadherins (P)
shows that N-cadherin null clones clearly express some other
member of the cadherin family of cell adhesion proteins. Lysed
mouse brain tissue (BR) served as control for the 135-kD N-cad-
herin protein. 
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Discussion
 
The ability to produce homozygous null somatic cells in
culture allows a genetic analysis of the function of mole-
cules in differentiated cells in a manner that is not always
possible in whole animals. This is particularly clear in cases
in which the null mutation of interest results in embryonic
lethality before the development of the tissue of interest,
as in the case of N-cadherin. Viability as a cell monolayer
in vitro presumably does not impose the same stringent se-
lective pressures as are required for viability and develop-
ment of an intact animal, thus functional compensation by
other molecules may occur less frequently. Therefore, ap-
plication of a genetic approach to cultured somatic cells
should prove useful in some cases in which no phenotype
is observed in the mouse. In either case, genotype conver-
sion in vitro could provide an indication of the function of
particular molecules that may be missed by targeted gene
inactivation in the whole animal.
The approach for obtaining homozygous null somatic
cells described in this report is a modification of that previ-
ously reported for ES cells (26). The precise molecular
mechanism by which most heterozygous ES cells or the
N-cadherin heterozygous myoblasts described here are
rendered null, remains unknown. However, since no phe-
notype was apparent in N-cadherin null myoblast clones,
major disruptions such as chromosomal loss or duplication
seem less likely than homologous recombination at mitosis
Figure 2. Similar kinetics
and extent of fusion of pri-
mary myoblasts expressing
or lacking N-cadherin. (A;
graphs) A biochemical
chemiluminescence assay of
fusion gave similar results to
the fusion index, or percent-
age of total nuclei in myo-
tubes. (A; greyscale images)
Micrographs of fusing N-cad-
herin 1/2 or 2/2 myoblasts
after 55 h in DM. (B) Activ-
ity of functional comple-
mented b-galactosidase in
fused cells detected at the
single cell level by fluor-X-
gal (green) together with nu-
clei (blue) and myotube
membrane marker (red).
Bars: (A) 50 mm; (B) 10 mm.  
Charlton et al.
 
 Fusion Competence of N-Cadherin Null Myoblasts
 
335
 
leading to increased expression of the neo gene used for
selection.
The process by which muscle cells interact and fuse to
produce syncytia has been studied for decades and yet re-
mains largely unknown. Myoblasts of different species rec-
ognize one another, adhere and fuse to form heterokaryon
myotubes, yet very rarely spontaneously fuse with cells
from other tissues (2). A number of molecules have been
implicated in the adhesion and fusion of myoblasts, includ-
ing N-, M-, and R-cadherin, neural cell adhesion molecule
(NCAM), vascular cell adhesion molecule (VCAM-1),
meltrin, and various integrins (7, 18, 22, 23, 32, 38, 40). In
some cases, these molecules were thought to be involved
due to increased fusion observed upon over-expression (7,
40). In other cases, both inhibition of aggregation and fu-
sion were documented in response to antibodies or pep-
tide mimics (17, 18, 22, 23, 32, 40). The generation of trans-
genic animals with targeted deletions in genes for a couple
of these molecules, N-cadherin and 
 
a
 
-4 integrin (30, 41),
recently allowed homozygous null myoblasts to be isolated
from mouse tissues and selected after growth in G418 in tis-
sue culture. Using a genetic approach, 
 
a
 
-4 integrin, like
N-cadherin shown here, has proven not to be essential to
myogenesis. These findings raise questions regarding the
results of previous studies that employed over-expression
or blocking agents such as antibodies or peptides to prove
that a molecule has a role in the fusion of myoblasts.
Blocking agents may have indirect effects such as nonspe-
cific binding, steric hindrance, and initiation of signal
transduction (6, 24, 34). A genetic approach provides the
most stringent test of the function of a molecule. If a gene
is deleted and a process continues, the specific molecule
encoded by that gene is clearly not required, as is the case
for N-cadherin in myoblast fusion.
However, genetic studies that lead to the elimination of
a molecule such as N-cadherin do not exclude the possibil-
ity that other molecules may function in place of the tar-
geted one (16). It has long been known that cadherins, by
virtue of their homophilic binding, play a role in aggrega-
tion of like cell types (11, 35). There is also suggestive evi-
dence that a cadherin may be important in signaling myo-
genic differentiation and that one cadherin may replace
another in this role (15). Indeed, muscle has been reported
to express several other cadherins, including M- and R-cad-
herins, that have been suggested to play roles in myogene-
sis (21). We have shown in this report that cadherins other
Figure 3. Fusion of N-cadherin homozygous null, heterozygous, and wild-type myoblasts with multinucleate myofibers in vivo.
N-cadherin  2/2,  1/2, and 1/1 primary myoblasts were each transduced with retroviral constructs containing the full-length lacZ gene
and then injected into the tibialis anterior muscles of nude mice. At 2 d, myoblasts were present in unfused clusters (shown here for 1/1,
upper left). By 12 d after injection for all phenotypes (1/1, top right, 1/2, bottom left, and 2/2, bottom right) lacZ expression was also
similar but appeared in fields of hundreds of large-diameter muscle fibers indicative of fusion with pre-existing host fibers. Bar, 60 mm.
Figure 4. bFGF inhibition of fusion of N-cadherin–lacking and
-expressing myoblasts. b-Galactosidase activity in 50-h fusing co-
cultures of homozygous N-cadherin null (s) and wild-type (j)
myoblasts treated with different concentrations of bFGF in DM
was measured by chemiluminescent assay. Standard deviations
were calculated on data expressed as percent maximal fusion,
normalized by the equation (Y-Yo)/Ymax-Yo, where Y is individ-
ual measure of luminescent counts per second (LCPS) for a given
well, Yo is mean LCPS value for that point, and Ymax is mean
LCPS value at point of maximum fusion where FGF 5 0 ng/ml.The Journal of Cell Biology, Volume 138, 1997 336
than N-cadherin are present on N-cadherin null myoblasts.
These cadherins or other adhesion molecules could as-
sume its role. Thus, the present study does not rule out the
possibility that N-cadherin participates in aggregation, dif-
ferentiation, or fusion. However, its role in these pro-
cesses, if it has one, is definitely not essential.
In conclusion, targeted gene inactivation now allows a
rigorous genetic analysis of the function of specific mole-
cules, not only in developing mice, but also in the cultured
somatic cells derived from their adult tissues. Thus, the ap-
proach described here for studying the role of N-cadherin
in muscle cell fusion has potential for determining the im-
portance of diverse molecules to the process of myogene-
sis and could well be extended to a range of other somatic
cell types.
We thank Randall Morris for providing access to the Wallac scintillation
counter, Susan Palmieri for help with the deconvolution microscope, and
members of our laboratory for thoughtful reviewing of the manuscript.
This work was funded by grants from the National Institutes of Health
(HD-18179, CA-59717, and AG-09521) and the Muscular Dystrophy As-
sociation of America to H.M. Blau, and from the National Heart Lung
and Blood Institute (P01-HL41484), the National Cancer Institute (R01-
CA17007), and the Howard Hughes Medical Institute to R.O. Hynes.
W.A. Mohler was supported by National Institutes of Health Predoctoral
Training Grants GM-07149, HD-07249, and GM-08412.
Received for publication 23 December 1996 and in revised form 20 May
1997.
References
1. Bavisotto, L.M., S.M. Schwartz, and R.L. Heimark. 1990. Modulation of
Ca2(1)-dependent intercellular adhesion in bovine aortic and human um-
bilical vein endothelial cells by heparin-binding growth factors. J. Cell.
Physiol. 143:39–51.
2. Blau, H.M., C.-P. Chiu, and C. Webster. 1983. Cytoplasmic activation of
human nuclear genes in stable heterokaryons. Cell. 32:1171–1180.
3. Brand-Saberi, B., A.J. Gamel, V. Krenn, T.S. Muller, J. Wilting, and B.
Christ. 1996. N-cadherin is involved in myoblast migration and muscle
differentiation in the avian limb bud. Dev. Biol. 178:160–173.
4. Braun, T., M.A. Rudnicki, H.H. Arnold, and R. Jaenisch. 1992. Targeted
inactivation of the muscle regulatory gene Myf-5 results in abnormal rib
development and perinatal death. Cell. 71:369–382.
5. Cremer, H., R. Lange, A. Christoph, M. Plomann, G. Vopper, J. Roes, R.
Brown, S. Baldwin, P. Kraemer, S. Scheff, et al. 1994. Inactivation of the
N-CAM gene in mice results in size reduction of the olfactory bulb and
deficits in spatial learning. Nature (Lond.). 367:455–459.
6. Diaz-Gonzalez, F., J. Forsyth, B. Steiner, and M.H. Ginsberg. 1996. Trans-
dominant inhibition of integrin function. Mol. Biol. Cell. 7:1939–1951.
7. Dickson, G., D. Peck, S.E. Moore, C.H. Barton, and F.S. Walsh. 1990. En-
hanced myogenesis in NCAM-transfected mouse myoblasts. Nature
(Lond.). 344:348–351.
8. Duband, J.L., S. Dufour, K. Hatta, M. Takeichi, G.M. Edelman, and J.P.
Thiery. 1987. Adhesion molecules during somitogenesis in the avian em-
bryo. J. Cell Biol. 104:1361–1374.
9. Fassler, R., and M. Meyer. 1995. Consequences of lack of b1 integrin gene
expression in mice. Genes Dev. 9:1896–1908.
10. Fredette, B., U. Rutishauser, and L. Landmesser. 1993. Regulation and ac-
tivity-dependence of N-cadherin, NCAM isoforms, and polysialic acid on
chick myotubes during development. J. Cell Biol. 123:1867–1888.
11. Geiger, B., and O. Ayalon. 1992. Cadherins. Annu. Rev. Cell Biol. 8:307–332.
12. Gumbiner, B.M. 1996. Cell adhesion: the molecular basis of tissue architec-
ture and morphogenesis. Cell. 84:345–357.
13. Hasty, P., A. Bradley, J.H. Morris, D.G. Edmondson, J.M. Venuti, E.N. Ol-
son, and W.H. Klein. 1993. Muscle deficiency and neonatal death in mice
with a targeted mutation in the myogenin gene. Nature (Lond.). 364:501–
506.
14. Hatta, K., S. Takagi, H. Fujisawa, and M. Takeichi. 1987. Spatial and tem-
poral expression pattern of N-cadherin cell adhesion molecules corre-
lated with morphogenetic processes of chicken embryos. Dev. Biol. 120:
215–227.
15. Holt, C.E., P. Lemaire, and J.B. Gurdon. 1994. Cadherin-mediated cell in-
teractions are necessary for the activation of MyoD in Xenopus meso-
derm. Proc. Natl. Acad. Sci. USA. 91:10844–10848.
16. Hynes, R.O. 1996. Targeted mutations in cell adhesion genes: what have we
learned from them? Dev. Biol. 180:402–412.
17. Knudsen, K.A., S.A. McElwee, and L. Myers. 1990. A role for the neural
cell adhesion molecule, NCAM, in myoblast interaction during myogene-
sis. Dev. Biol. 138:159–168.
18. Knudsen, K.A., L. Myers, and S.A. McElwee. 1990. A role for the Ca2(1)-
dependent adhesion molecule, N-cadherin, in myoblast interaction dur-
ing myogenesis. Exp. Cell Res. 188:175–184.
19. MacCalman, C.D., N. Bardeesy, P.C. Holland, and O.W. Blaschuk. 1992.
Noncoordinate developmental regulation of N-cadherin, N-CAM, inte-
grin, and fibronectin mRNA levels during myoblast terminal differentia-
tion. Dev. Dyn. 195:127–132.
20. Matsunami, H., and M. Takeichi. 1995. Fetal brain subdivisions defined by
R- and E-cadherin expressions: evidence for the role of cadherin activity
in region-specific, cell–cell adhesion. Dev. Biol. 172:466–478.
21. McDonald, K.A., A.F. Horwitz, and K.A. Knudsen. 1995. Adhesion mole-
cules and skeletal myogenesis. Semin. Dev. Biol. 6:105–116.
22. Mege, R.M., D. Goudou, C. Diaz, M. Nicolet, L. Garcia, G. Geraud, and F.
Rieger. 1992. N-cadherin and N-CAM in myoblast fusion: compared lo-
calisation and effect of blockade by peptides and antibodies. J. Cell Sci.
103:897–906.
23. Menko, A.S., and D. Boettiger. 1987. Occupation of the extracellular ma-
trix receptor, integrin, is a control point for myogenic differentiation.
Cell. 51:51–57.
24. Meyer, R.A., D.W. Laird, J.P. Revel, and R.G. Johnson. 1992. Inhibition of
gap junction and adherens junction assembly by connexin and A-CAM
antibodies. J. Cell Biol. 119:179–189.
25. Mohler, W.A., and H.M. Blau. 1996. Gene expression and cell fusion ana-
lyzed by lacZ complementation in mammalian cells. Proc. Natl. Acad.
Sci. USA. 93:12423–12427.
26. Mortensen, R.M., D.A. Conner, S. Chao, A.A. Geisterfer-Lowrance, and
J.G. Seidman. 1992. Production of homozygous mutant ES cells with a
single targeting construct. Mol. Cell Biol. 12:2391–2395.
27. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, I. Nonaka, and
Y. Nabeshima. 1993. Myogenin gene disruption results in perinatal le-
thality because of severe muscle defect. Nature (Lond.). 364:532–535.
28. Nolan, G.P., S. Fiering, J.F. Nicolas, and L.A. Herzenberg. 1988. Fluores-
cence-activated cell analysis and sorting of viable mammalian cells based
on b-d-galactosidase activity after transduction of Escherichia coli lacZ.
Proc. Natl. Acad. Sci. USA. 85:2603–2607.
29. Partridge, T.A., J.E. Morgan, G.R. Coulton, E.P. Hoffman, and L.M.
Kunkel. 1989. Conversion of mdx myofibres from dystrophin-negative to
-positive by injection of normal myoblasts. Nature (Lond.). 337:176–179.
30. Radice, G.L., H. Rayburn, H. Matsunami, K.A. Knudsen, M. Takeichi, and
R.O. Hynes. 1997. Developmental defects in mouse embryos lacking
N-cadherin.  Dev. Biol. 181:64–78.
31. Rando, T.A., and H.M. Blau. 1994. Primary mouse myoblast purification,
characterization, and transplantation for cell-mediated gene therapy. J.
Cell Biol. 125:1275–1287.
32. Rosen, G.D., J.R. Sanes, R. LaChance, J.M. Cunningham, J. Roman, and
D.C. Dean. 1992. Roles for the integrin VLA–4 and its counter receptor
VCAM-1 in myogenesis. Cell. 69:1107–1119.
33. Rudnicki, M.A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation
of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5
and results in apparently normal muscle development. Cell. 71:383–390.
34. Schachner, M. 1993. The analysis of neural recognition molecules: benefits
and vicissitudes of functional knock-outs using antibodies and gene abla-
tion. Curr. Opin. Cell Biol. 5:786–790.
35. Takeichi, M. 1991. Cadherin cell adhesion receptors as a morphogenetic
regulator. Science (Wash. DC). 251:1451–1455.
36. Williams, E.J., J. Furness, F.S. Walsh, and P. Doherty. 1994. Activation of
the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM,
and N-cadherin. Neuron. 13:583–594.
37. Williams, E.J., J. Furness, F.S. Walsh, and P. Doherty. 1994. Characterisa-
tion of the second messenger pathway underlying neurite outgrowth
stimulated by FGF. Development. 120:1685–1693.
38. Yagami-Hiromasa, T., T. Sato, T. Kurisaki, K. Kamijo, Y. Nabeshima, and
A. Fujisawa-Sehara. 1995. A metalloprotease-disintegrin participating in
myoblast fusion. Nature (Lond.). 377:652–656.
39. Yang, J.T., T.A. Rando, W.A. Mohler, H. Rayburn, H.M. Blau, and R.O.
Hynes. 1996. Genetic analysis of a-4 integrin functions in the develop-
ment of mouse skeletal muscle. J. Cell Biol. 135:829–835.
40. Zeschnigk, M., D. Kozian, C. Kuch, M. Schmoll, and A. Starzinski-Powitz.
1995. Involvement of M-cadherin in terminal differentiation of skeletal
muscle cells. J. Cell Sci. 108:2973-2981.